[HTML][HTML] Untargeted urinary metabolomics for bladder cancer biomarker screening with ultrahigh-resolution mass spectrometry
Bladder cancer (BC) is a common urological malignancy with a high probability of death and
recurrence. Cystoscopy is used as a routine examination for diagnosis and following patient …
recurrence. Cystoscopy is used as a routine examination for diagnosis and following patient …
[HTML][HTML] Applications of exosomes in diagnosing muscle invasive bladder cancer
JM Walker, P O'Malley, M He - Pharmaceutics, 2022 - mdpi.com
Muscle Invasive Bladder Cancer (MIBC) is a subset of bladder cancer with a significant risk
for metastases and death. It accounts for nearly 25% of bladder cancer diagnoses. A …
for metastases and death. It accounts for nearly 25% of bladder cancer diagnoses. A …
Structural or functional defects of PTEN in urothelial cells lacking P53 drive basal/squamous-subtype muscle-invasive bladder cancer
Muscle-invasive bladder cancer (MIBC) exhibits strong inter-and intra-tumor heterogeneity
that affects biological behaviors, therapeutic responses, and prognoses. Mutations that …
that affects biological behaviors, therapeutic responses, and prognoses. Mutations that …
[HTML][HTML] DNMT3A/miR-129-2-5p/Rac1 Is an Effector Pathway for SNHG1 to Drive Stem-Cell-like and Invasive Behaviors of Advanced Bladder Cancer Cells
J Xu, R Yang, J Li, L Wang, M Cohen, DM Simeone… - Cancers, 2022 - mdpi.com
Simple Summary Bladder cancer ranks fourth among the most prevalent cancers in men and
is the most expensive cancer to treat on a per-patient basis. The muscle-invasive form of …
is the most expensive cancer to treat on a per-patient basis. The muscle-invasive form of …
Targeting Chemoresistance in Advanced Bladder Cancers with a Novel Adjuvant Strategy
JR Seremak, KB Gupta, S Bonigala, E Liu… - Molecular Cancer …, 2024 - AACR
Advanced urinary bladder cancer is characterized by rapid progression and development of
therapy resistance. About 30% of the patients are diagnosed with high-grade tumors …
therapy resistance. About 30% of the patients are diagnosed with high-grade tumors …
Recent advances in the understanding of urothelial tumorigenesis
M Yasui, L Cui, H Miyamoto - Expert Review of Anticancer Therapy, 2023 - Taylor & Francis
Introduction Patients with non-muscle-invasive bladder tumor suffer from disease recurrence
following transurethral surgery even with intravesical pharmacotherapy, while muscle …
following transurethral surgery even with intravesical pharmacotherapy, while muscle …
[HTML][HTML] Depletion of the m1A writer TRMT6/TRMT61A reduces proliferation and resistance against cellular stress in bladder cancer
I Monshaugen, L Luna, J Rhodes… - Frontiers in …, 2024 - frontiersin.org
Background Bladder cancer (BLCA) is a common and deadly disease that results in a
reduced quality of life for the patients and a significant economic burden on society. A better …
reduced quality of life for the patients and a significant economic burden on society. A better …
Integrated bioinformatics analysis identifies a Ferroptosis-related gene signature as prognosis model and potential therapeutic target of bladder cancer
Z Liu, D Du, S Zhang - Toxicology Research, 2024 - academic.oup.com
Background Bladder cancer (BLCA) is one of the most prevalent cancers worldwide.
Ferroptosis is a newly discovered form of non-apoptotic cell death that plays an important …
Ferroptosis is a newly discovered form of non-apoptotic cell death that plays an important …
Recent Progress in Urothelial Bladder Carcinoma: Basic Biology, Molecular Characterization, Conventional and Innovative Therapies and Tumour–Stroma …
J Hatina, M Kripnerová, K Houfková, M Hajdůšková… - 2022 - Springer
Urothelial bladder carcinoma is a cancer type featuring a pronounced heterogeneity. Two
major types, the Non-Muscle-Invasive Bladder Carcinoma (NMIBC) and the Muscle-Invasive …
major types, the Non-Muscle-Invasive Bladder Carcinoma (NMIBC) and the Muscle-Invasive …
[PDF][PDF] Applications of Exosomes in Diagnosing Muscle Invasive Bladder Cancer. Pharmaceutics 2022, 14, 2027
JM Walker, P O'Malley, M He - 2022 - pdfs.semanticscholar.org
Muscle Invasive Bladder Cancer (MIBC) is a subset of bladder cancer with a significant risk
for metastases and death. It accounts for nearly 25% of bladder cancer diagnoses. A …
for metastases and death. It accounts for nearly 25% of bladder cancer diagnoses. A …